Status:

COMPLETED

Mechanisms of Smell Improvement With Dupilumab.

Lead Sponsor:

Medical University of South Carolina

Conditions:

Chronic Rhinosinusitis With Nasal Polyps

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

This study seeks to explore the mechanism through which dupilumab improves olfactory cleft inflammation in patients with chronic sinusitis with nasal polyps (CRSwNP). The investigators expect this stu...

Detailed Description

Post-marketed administration of dupilumab (FDA approved medication for CRSwNP) in patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) will result in significant improvement in objective me...

Eligibility Criteria

Inclusion

  • Adults ≥18 years of age
  • Meet criteria for CRSwNP as defined by ICAR-21
  • 2 out of 4 cardinal symptoms for ≥12 weeks
  • Visible evidence of inflammation on endoscopy or imaging
  • Bilateral visible nasal polyps ≥1 in each nasal cavity (0-4 scale each side)
  • Olfaction score ≥1 (0-3 scale)
  • Candidate for treatment with dupilumab for CRSwNP
  • Elected to proceed with dupilumab for treatment of CRSwNP

Exclusion

  • Prior use of dupilumab
  • Previous treatment with another biologic medication for CRSwNP or asthma within 6 months
  • Any nasal or sinus surgery within the last 3 months
  • Oral corticosteroid use within the last 1 month
  • Current pregnancy, breast-feeding, or plan to become pregnant during next 3 months
  • Presence of antrochoanal nasal polyps; acute rhinosinusitis; upper respiratory infection;
  • Allergic granulomatous angiitis/eosinophilic granulomatosis with polyangiitis;
  • Granulomatosis with polyangiitis; cystic fibrosis; Young syndrome;
  • Kartagener syndrome; or dyskinetic cilia syndrome
  • Poorly controlled asthma

Key Trial Info

Start Date :

August 10 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 30 2025

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT05964465

Start Date

August 10 2023

End Date

January 30 2025

Last Update

March 5 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Medical University of South Carolina

Charleston, South Carolina, United States, 29425

2

University of Virginia

Charlottesville, Virginia, United States, 22904